DATONE CLINIC in Cheongdam, Seoul Introduces TEOXANE, a Premium Swiss Hyaluronic Acid Filler Brand
Journal
DATONE CLINIC, located in Cheongdam-dong, Seoul, South Korea, has announced the introduction of TEOXANE, a premium Swiss hyaluronic acid (HA) filler brand, further strengthening its commitment to personalized aesthetic medicine that celebrates individual beauty and natural facial harmony.
At the heart of DATONE CLINIC's philosophy is the belief: "We don't change you. We refine your tone."
Rather than applying standardized beauty ideals, the clinic embraces the concept of "Your Own Tone," focusing on each individual's unique facial features, skin characteristics, and personal aesthetic identity to achieve natural, harmonious refinement.
This philosophy closely aligns with TEOXANE's approach to facial aesthetics, which recognizes the face not as a static structure but as a dynamic expression of movement and emotion.
Built upon advanced hyaluronic acid science and RHA® (Resilient Hyaluronic Acid) technology, TEOXANE has developed a portfolio of dermal fillers designed with consideration for both facial anatomy and natural facial movement.
Through the introduction of TEOXANE, DATONE CLINIC aims to further enhance its approach to Personalized Aesthetics, taking into account each patient's facial structure, dynamic expressions, skin condition, and desired degree of aesthetic enhancement.
Dr. Yeorim Ahn, Medical Director of DATONE CLINIC, stated:
"Good aesthetic medicine is not about reshaping someone's face to resemble another person's. It is about naturally bringing out the unique beauty, character, and expression that each individual already possesses."
She added:
"I believe there is a strong connection between DATONE CLINIC's philosophy of 'Your Own Tone' and TEOXANE's commitment to natural facial movement and harmony."
Kang Wook Lee, CEO of Global Aesthetics, commented:
"We aim to create a differentiated treatment experience by connecting DATONE CLINIC's distinctive aesthetic philosophy with TEOXANE's scientific innovation and clinical value."
He further stated:
"We will continue to develop premium brand strategies tailored to each clinic's philosophy and professional expertise."